FDA advisers endorse updating COVID vaccines to target latest omicron strain

The COVID-19 vaccines are on track for a big recipe change this fall. Thursday, the Food and Drug Administration’s scientific advisers said the next round of shots in the U.S. should only include protection against the newest variants that are now dominant worldwide — a branch of the omicron family tree named XBB.

Related posts